Spartan Bioscience Inc.: federal grants and contributions

Updated 12 October 2026 · Ottawa|Ottawa, ON · grants and contributions register · Ottawa Centre

Spartan Bioscience Inc.: federal grants and contributions: 10 agreements; $4.2M value; 2 departments; 4 programs.

Assay record ASY-CA-1FSEGOI188 · Cite as: Assay Systems, “Spartan Bioscience Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/spartan-bioscience-inc/

$
10agreements
$4.2Mvalue
2departments
4programs

Largest agreements

815966$2.8Mvalue2020start2021end

The project is to undertake the commercialization and manufacturing of sample preparation kits and test cartridges that accompany the Spartan Cube Covid-19 testing system.

COVID-19 Test Development$688Kvalue2020start2020end

Spartan Bioscience (Spartan) proposes development of a SARS-CoV-2 assay to operate on its Cube sample-to-result real-time PCR testing platform. The proposed assay will have a simple workflow requiring no sample preparation after sample collection. The portable size of the Cube, along with the simplicity of the proposed workflow allows the solution to be deployed and implemented into airports, border crossings, and critical national infrastructure with ease.

Temperature-stable DNA test cartridges for Legionella$349Kvalue2018start2019end

Spartan Bioscience has developed the world’s first on-site Legionella DNA test to prevent Legionnaires’ disease outbreaks. This project will enable Spartan to develop room-temperature stable cartridges to improve shelf life and shipping requirements.

Entering European Markets with Spartan’s Medical Platform: rapid CYP2C19 testing and portable COVID19 testing$75.0Kvalue2020start2021end

To commercialize Spartan’s medical platform. We are commercializing the CYP2C19 test upon the success of the European landmark POPular Genetics clinical trial and the COVID19 test to fight the global pandemic.

Creating international markets for on-site Legionella DNA testing$74.6Kvalue2019start2020end

Spartan has created the first on-site Legionella DNA test to prevent Legionnaires’ disease outbreaks. This project will enable Spartan to build on our initial success in North America and export the test to a key export markets.

Agreement$32.9Kvalue2017start–end
Agreement$30.0Kvalue2017start–end
YOUTH: Legionella Detection System user interface$30.0Kvalue2017start2018end

The project involves human factors testing of a new user interface for Spartan's Legionella Detection System.

Agreement$29.1Kvalue2009start–end
Agreement$27.0Kvalue2009start–end

Departments

Federal Economic Development Agency for Southern Ontario1agreements$2.8Mvalue1programs
  • Business Scale-Up

All grants from Federal Economic Development Agency for Southern Ontario

National Research Council Canada9agreements$1.3Mvalue3programs
  • Industrial Research Assistance Program – Contributions to Firms
  • CanExport SMEs
  • Industrial Research Assistance Program – Youth Employment Program

All grants from National Research Council Canada

Years

20203agreements$3.6Mvalue3programs
  • Business Scale-Up
  • Industrial Research Assistance Program – Contributions to Firms
  • CanExport SMEs
20191agreements$74.6Kvalue1programs
  • CanExport SMEs
20181agreements$349Kvalue1programs
  • Industrial Research Assistance Program – Contributions to Firms
20173agreements$92.9Kvalue1programs
  • Industrial Research Assistance Program – Youth Employment Program
20092agreements$56.2Kvalue0programs

    Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.